ADVERTISEMENT
person in white jacket putting bandaid on arm of child
Can We Predict How Well Someone Will Respond to a Vaccine?
Researchers find signatures pre- and post-vaccination that correlate with a more robust immune response. 
Can We Predict How Well Someone Will Respond to a Vaccine?
Can We Predict How Well Someone Will Respond to a Vaccine?

Researchers find signatures pre- and post-vaccination that correlate with a more robust immune response. 

Researchers find signatures pre- and post-vaccination that correlate with a more robust immune response. 

antibody
Man in lab coat looking at the camera and smiling
Can Taking a Test Now Tell You if You’ve Already Had COVID-19?
Natalia Mesa, PhD | Aug 8, 2022 | 4 min read
The Scientist asks Brigham and Women’s Hospital infectious disease specialist Lindsey Baden about testing for prior infections.
illustration of inside of gut with floating bacteria
Finding Could Pave the Way to New, Targeted Antibody Treatments
Natalia Mesa, PhD | Jul 8, 2022 | 3 min read
IgA antibodies appear to bind to specific species of commensal gut bacteria in mice, according to a study.
Technique Talk: Turning the PAGE—The Dos and Don’ts of Protein Electrophoresis and Western Blotting 
Technique Talk: Turning the PAGE—The Dos and Don’ts of Protein Electrophoresis and Western Blotting
The Scientist’s Creative Services Team and Merck | 1 min read
In this webinar, Kelly Wolfe will discuss innovations that streamline western blotting workflows.
Vaccine illustration 
Infographic: Inducing Active Immunity Against Opioid Overdose
Tori Rodriguez | Jun 13, 2022 | 3 min read
How scientists aim to induce an immune response against addictive drugs
Illustration of a syringe with a person falling out of a bottle of pills
Opioid Vaccines as a Tool to Stem Overdose Deaths
Tori Rodriguez | Jun 13, 2022 | 10+ min read
Researchers are turning to the immune system for help in treating addiction and preventing overdose.
Technique Talk: Turning the PAGE—The Dos and Don’ts of Protein Electrophoresis and Western Blotting 
Technique Talk: Turning the PAGE—The Dos and Don’ts of Protein Electrophoresis and Western Blotting
The Scientist’s Creative Services Team and MilliporeSigma | 1 min read
In this webinar, Kelly Wolfe will discuss innovations that streamline western blotting workflows.
Updated Mar 8
A healthcare worker holds up three syringes with clear medicine
To Booster or Not: Scientists and Regulators Debate
Jef Akst | Sep 16, 2021 | 7 min read
President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.
A vial containing a red blood sample is balanced on its end on a table or desk by someone wearing a blue medical glove on their right hand
New Evidence Shows COVID-19 Was in US Weeks Before Thought
Abby Olena, PhD | Jun 17, 2021 | 4 min read
Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.
A New Multiplexed SARS-CoV-2 Serological Assay Using Advanced Flow Cytometry
A New Multiplexed SARS-CoV-2 Serological Assay Using Advanced Flow Cytometry
The Scientist’s Creative Services Team | 1 min read
Julie Lovchik will discuss how advanced flow cytometry instrumentation facilitates multiplex assessment of IgG, IgM, and IgA antibodies against SARS-CoV-2.
COVID-19, SARS-CoV-2, coronavirus, pandemic, pseudovirus, chimeric virus, disease & medicine, techniques, HIV, VSV, vaccine, variants, mutations
What Pseudoviruses Bring to the Study of SARS-CoV-2
Amanda Heidt | Feb 16, 2021 | 7 min read
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
Abby Olena, PhD | Feb 16, 2021 | 4 min read
Researchers identify deletions in the N-terminal domain of the spike protein that allow the coronavirus to avoid antibody neutralization and that may contribute to the emergence of new variants.
Learn How the Immune System Can Be Trained to Overcome Food Allergies
Retraining the Immune System Cavalry for Food Allergen Peacekeeping Missions
The Scientist’s Creative Services Team | 1 min read
Explore food allergy immunotherapy for reversing patient symptoms.
Vaccines Versus the Mutants
Anthony King | Feb 8, 2021 | 7 min read
Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them.
COVID-19 May Have Arrived in US in December: Study
Max Kozlov | Dec 2, 2020 | 2 min read
SARS-CoV-2 antibodies detected in blood donor samples indicate infections could have occurred in the US more than a month before the first confirmed case, but some experts remain skeptical.
Technique Talk: Straightening Out Messy Western Blots
Technique Talk: Straightening Out Messy Western Blots
The Scientist’s Creative Services Team | 1 min read
In this webinar, Aldrin Gomes will reveal how to obtain reproducible, publication-ready western blot images.
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Anthony King | Nov 11, 2020 | 5 min read
Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 
Vast Majority in US Remain Susceptible to COVID-19: Study
Max Kozlov | Sep 28, 2020 | 2 min read
Fewer than 1 in 10 dialysis patients sampled had antibodies against the novel coronavirus as of July, indicating that the greater population is far from levels required to achieve herd immunity.
Learn About Sero-Surveillance During the COVID-19 Pandemic
Using Sero-Surveillance to Combat the COVID-19 Pandemic
The Scientist’s Creative Services Team and Bio-Rad Laboratories | 1 min read
Immunoassays for detecting, tracking, and testing SARS-CoV-2 antibody responses
adenovirus vector vaccine covid-19 pandemic coronavirus sars-cov-2 spike protein
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Anthony King | Sep 8, 2020 | 6 min read
Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?
ADVERTISEMENT